Senators slam the FDA’s new vape enforcement plan

The FDA and the DOJ claim they're getting serious about clearing store shelves of illegal vapes. Lawmakers made clear they aren't buying it.

June 12, 2024 Check out STAT+

Sponsored By

Jose Luis Magana/AP Senators slam the FDA's new vape enforcement plan: 'What in the hell have you been waiting for?' The hearing was the clearest sign to date that both parties have become fed up with the countless illegal e-cigarettes on store shelves. By Nicholas Florko Michigan stands out for its aggressive bird flu response. Will other states follow its lead? Michigan draws praise for its transparency and testing for H5N1 bird flu; pandemic preparedness experts hope other states will learn from it. By Megan Molteni NIH wanted to make cancer research more diverse. The effort turned out to be a costly failure Cancer researchers tested out paying for more travel costs for patients, but the effort didn't result in more diverse trials. By John Wilkerson Jose Jimenez/Primera Hora/Getty Images World Trade Center responders exposed to more dust saw higher risk of early dementia Study published in JAMA Network Open found a correlation between higher rates of dementia and higher levels of particulate exposure in 5,000 9/11 responders. By Annalisa Merelli STAT+ | New AI for biopsies can analyze microscopy images, talk to pathologists about your tumor PathChat is a new AI model for pathology, published Wednesday in Nature by Harvard researcher Faisal Mahmood and his collaborators. By Brittany Trang Opinion: Getting farmworkers to use PPE is hard, but it's the best way to stop an H5N1 bird flu epidemic Experts say the most effective way to ward off a potential H5N1 bird flu crisis — and protect farmworkers — is to ensure workers have practical, effective PPE. By Ranu Dhillon and Devabhaktuni Srikrishna Watch: The role of PBMs, patents, and public health in drug pricing Part 1 of "Behind the Counter," a STAT video series examining why prescription drug prices are so high, and how drugmakers, insurers, and PBMs play a role. By Anna Yeo Opinion: The J&J lawsuit should be a wakeup call to the PBM industry — and to companies everywhere There is an urgent need for a shift toward a more transparent, comprehensive approach in PBM evaluation and selection. By Jake Frenz Three scientists win Kavli Prize for nanoscience in biomedicine Robert Langer, Paul Alivisatos, and Chad Mirkin were awarded the 2024 Kavli nanoscience prize for their seminal work in biomedicine. By Rohan Rajeev

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser